All News

A patient with MPN urges others to ask questions about treatment options, which may also include inquiring about clinical trials.

In patients with triple-negative breast cancer, ctDNA was most commonly identified within six months after treatment, reflecting the disease’s typical pattern of early recurrence.

As I prepare for treatment of my chronic lymphocytic leukemia, I reflect on the challenges of aging and side effects while staying focused on living fully.

CURE created a list of the top breast cancer stories of this year, including those focused on patient-reported outcomes and side effect management, among others.

Carla Chapman, a nurse at Dana-Farber Cancer Institute, is recognized for her unwavering support of patients, while Deb Christensen, an oncologist and patient advocate, dedicates her life to helping patients through volunteer work and education.

A clinical trial manager emphasizes the importance of a phased approach to educating patients about complex protocols and potential side effects.

A patient advocate says that patients with breast cancer may find it challenging to feel "normal," but reconstruction advancements may help.

Receiving a diagnosis of colon cancer at age 34 was such a shocking experience, but it has helped me become more strong-willed.

Throughout the year, CURE® contributors shared personal stories and reflections highlighting the multifaceted nature of cancer care.

Former U.S. President Jimmy Carter called attention to the immunotherapy drug Keytruda, which was used to successfully treat his cancer.

Jade Distajo has made a profound impact on thousands of patients with her unwavering commitment to exceptional care, compassionate bedside manner and tireless support.

From the benefits of early adoption to the effectiveness of telehealth, here is what we reported about palliative care throughout the year.

Even after a personal connection to cancer, oncology nurse Megan has embraced the cancer space as her passion.

Treatment with five-fraction SBRT for prostate cancer may be more convenient than receiving traditional radiation therapy techniques, an expert said.

Opdivo Qvantig received FDA approval for all previously approved indications in solid tumors.

We, survivors, often express our gratitude for life, love, support and research, but what about the patients who do not experience positive outcomes from treatment?

This marks the second FDA approval of Tevimbra this year.

An MPN advocate used his personal experiences to inform his dedication to patient-centered research and support programs for patients.

A patient advocate discusses the difficulties of finding and participating in clinical trials for MPNs, and the impact on research and treatment development.

An expert spoke with CURE® about the importance of information that can be gained from genetic testing for patients with breast cancer.

Nearly 12 years after being diagnosed with ovarian cancer, Julie Brokaw believes life is a miracle.

CURE® highlights some of the top stories from SABCS, including those focused on older and younger patients with breast cancer, in addition to treatment strategies.

The treatment combination was found to reduce the risk of follicular lymphoma progression or death by 57%, a study has shown.

Monjuvi plus Revlimid and Rituxan demonstrated improved progression-free survival for patients with relapsed or refractory follicular lymphoma.

With breakthroughs from melanoma to pancreatic cancer, this has been a year of great promise in the field of cancer vaccines.

A health care professional talks about the importance of a supportive care team, especially since every patient with MPNs presents differently.

After sharing his cancer story online, Jace Yawnick is in a state of technical remission after receiving a diagnosis of non-Hodgkin lymphoma at age 25.

This Christmas, my wish for all of you is that you read this and feel seen, that someone out there knows how very hard this is for you.